Destaques

Manutenção da hidratação oral em idosos em enfermarias cirúrgicas: projeto de implementação de melhores práticas.

21 Mar, 2022 | 16:27h

Maintaining oral hydration in older adults in surgical wards: a best practice implementation project – JBI Evidence Implementation (gratuito por tempo limitado)

 

Comentário no Twitter

A timely and relevant article on this #WDAD2022. It is essential that basic needs like hydration, nutrition, movement, and sleep are addressed to prevent and mitigate negative outcomes for older persons, especially those at risk for #delirium.#research #practice @JBI_EI https://t.co/YzRWMiVMKQ

— Andrea Rochon (@AndreaRochon) March 17, 2022

 

---

Estudo mostra baixo risco de complicações após colocação de cateter intravenoso ipsilateral em pacientes cirúrgicas de câncer de mama.

21 Mar, 2022 | 16:26h

Ipsilateral Intravenous Catheter Placement in Breast Cancer Surgery Patients – Anesthesia & Analgesia (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

🙏🙏🙏 much-needed dogmalysis. I’ve seen situations where folks were afraid to even place a Bp cuff ipsilateral to prior mastectomy. this excessive fear impairs patient care. https://t.co/afjwjjseo7

— 𝙟𝙤𝙨𝙝 𝙛𝙖𝙧𝙠𝙖𝙨 💊 (@PulmCrit) March 17, 2022

 

---

Estudo transversal e metanálise | Avaliação da magnitude do viés de reportagem em estudos homeopáticos.

21 Mar, 2022 | 16:24h

Assessing the magnitude of reporting bias in trials of homeopathy: a cross-sectional study and meta-analysis – BMJ Evidence-Based Medicine

Comunicado de imprensa: Poor research practice suggests true impact of homeopathy may be “substantially” overestimated – BMJ Newsroom

 

Comentário no Twitter

Poor research practice suggests true impact of homeopathy may be “substantially” overestimated suggests @BMJ_EBM research https://t.co/5FvvJJJLX1 pic.twitter.com/2g5LWSvfYn

— BMJ (@bmj_company) March 16, 2022

 

---

Decisão do consenso de especialistas da ACC de 2022 sobre sequelas cardiovasculares de COVID-19 em adultos: miocardite e outros envolvimentos miocárdicos, sequelas pós-agudas da infecção pelo SARS-CoV-2 e volta aos esportes.

17 Mar, 2022 | 13:25h

2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee – Journal of the American College of Cardiology

Comentários:

ACC Issues Clinical Guidance on CV Consequences of COVID-19 – American College of Cardiology

ACC Releases Guidance on CV Issues With COVID-19 – TCTMD

Pontos principais: 2022 ACC Decision Pathway on Cardiovascular Sequelae of COVID-19

Conteúdos relacionados:

Review | Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.

The pathogenesis and long-term consequences of Covid-19 cardiac injury: state-of-the-art review.

COVID-19 infections increase risk of heart conditions up to a year later, study finds.

 

Comentário no Twitter (fio – clique para saber mais)

Access the full ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-acute Sequelae of SARS-CoV-2 Infection, and Return to Play: https://t.co/ph75qZxfpT #JACC @JACCJournals #CardioTwitter (8/8) pic.twitter.com/mpYJic6gem

— American College of Cardiology (@ACCinTouch) March 16, 2022

 

---

Revisão do estado de arte | Avanços recentes no diagnóstico e tratamento da cefaleia em salvas.

17 Mar, 2022 | 13:23h

Recent advances in the diagnosis and management of cluster headache – The BMJ

---

Evidências Cochrane | Tratamento para COVID-19 moderada a grave.

17 Mar, 2022 | 13:22h

Treatments for moderate to severe COVID-19: Cochrane evidence – Evidently Cochrane

---

Evidências Cochrane | Tratamento para COVID-19 leve.

17 Mar, 2022 | 13:20h

Treatments for mild COVID-19: Cochrane evidence – Cochrane Library

---

Entre profissionais da área da saúde, a efetividade da 4ª dose de vacina contra infecção pela variante Ômicron do SARS-CoV-2 foi de 30% para a Pfizer–BioNTech e 11% para a Moderna.

17 Mar, 2022 | 13:19h

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron – New England Journal of Medicine

Conteúdo relacionado: [Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.

---

Efetividade das vacinas Sputnik V, AstraZeneca e Sinopharm para o risco de infecção e morte por COVID-19 em idosos com mais de 60 anos na Argentina.

17 Mar, 2022 | 13:17h

Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study – The Lancet

Comentário: Evaluating COVID-19 vaccines in the real world – The Lancet

---

[Comunicado de imprensa – ainda não publicado] Estudo EMPA-KIDNEY de fase III sobre empaglifozina será interompido precocemente em razão de evidência da eficácia em pessoas com doença renal crônica.

17 Mar, 2022 | 13:16h

Jardiance® phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease – Lilly

Ver também: Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial – Nephrology Dialysis Transplantation

 

Comentário no Twitter

Details of the design & pt characteristics now published:

6609 people from 8 countries
(UK, Germany, Italy, USA, Canada, China, Malaysia, Japan)
Mean age 64 years
1/3 female
1/2 diabetes; 1/2 without
3/4 eGFR <45 mL/min/1.73 m2.
1/2 uACR <300 mg/g https://t.co/jOD8kyp3i4 pic.twitter.com/YYpGPJDnV9

— Martin Landray (@MartinLandray) March 16, 2022

 

---